Elevance Health, Inc. (ELV)
| Market Cap | 84.11B |
| Revenue (ttm) | 183.12B |
| Net Income (ttm) | 5.92B |
| Shares Out | 225.93M |
| EPS (ttm) | 25.60 |
| PE Ratio | 14.54 |
| Forward PE | 10.52 |
| Dividend | $6.84 (1.84%) |
| Ex-Dividend Date | Jun 10, 2025 |
| Volume | 2,480,112 |
| Open | 385.21 |
| Previous Close | 384.51 |
| Day's Range | 368.75 - 386.29 |
| 52-Week Range | 357.45 - 567.26 |
| Beta | 0.67 |
| Analysts | Buy |
| Price Target | 519.76 (+39.62%) |
| Earnings Date | Jul 16, 2025 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $519.76, which is an increase of 39.62% from the latest price.
News
ELV FRAUD: Suffer Losses on Elevance Health, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NYSE:ELV)
NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the C...
ELV FRAUD NEWS: Elevance Health, Inc. is Being Sued for Securities Fraud; Investors That Lost Money Are Urged to Contact BFA Law by July 11 Court Deadline
NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain...
ELV LAWSUIT: Lose Money on Elevance Health, Inc.? Contact BFA Law before July 11 Court Deadline
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the C...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. (ELV)
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of In...
Verily CEO tells staff the sale of its insurance business is a 'strategic win' as the deal closes
Elevance Health's acquisition of Verily's insurance business has closed. Verily's CEO told staff in a memo that the sale will strengthen the company's financial position.
10 Undervalued Dividend Growth Stocks: May 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...
DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks
The DOJ alleges in its complaint that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers eHealth, GoHealth and SelectQuote in exchange for enrollments into the insurers' M...
Elevance Health: Carelon Growth Not Fully Appreciated
Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid pressures r...
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Elevance Health, Inc. (NYSE:ELV) Q1 2025 Earnings Conference Call April 22, 2025 8:30 AM ET Company Participants Nathan Rich - VP, IR Gail Boudreaux - President & CEO Mark Kaye - CFO Felicia Norwood ...
Elevance confirms quarterly profit beat, reaffirms 2025 forecast
Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the preliminary estimates it released last week after bellwether UnitedHealth's lowered...
Elevance Health Reports First Quarter 2025 Results
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results. “At Elevance Health, our purpose—to improve the health of humanity—drives everything we do. In the...
Health insurer Elevance sees first-quarter profit above estimates
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence
Elevance Health's resilience in a volatile health insurance market is driven by its fee-based Commercial plans and preventive care initiatives. The company's focus on administrative services only plan...
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
GreensKeeper Q1 2025 Portfolio Update
Berkshire Hathaway led Q1 with a 17.5% return, driven by strong operating earnings and potential for significant acquisitions with over $300 billion in cash. Vertex Pharmaceuticals gained 20.4%, fuele...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare ...
Humana and Other Health Insurance Stocks Surge on Higher-Than-Expected Medicare Payments
Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
Health insurance stocks rise on 'best case scenario' Medicare payment rates
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare Advantage plans in 2026, bringing some relief to a sector bu...
Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath
Potato maker Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc., drug maker AbbVie Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to sto...
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key fa...
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last art...
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res...